arcabio.com | ARCA Biopharma

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:

Meta Tags

Title	ARCA Biopharma – Precision
Description	About ARCA Our Science Clinical Trials Collaborations Investors Contact Us About ARCA Our Science Clinical Trials Collaborations Investors Contact Us rNAP
Keywords	N/A

Server Information

WebSite	arcabio.com
Host IP	192.252.148.190
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

internalmedhouston.com

interstellardesign.com

arcabio.com Valuation

US$7,856,584

Last updated: 2023-05-08 04:03:23

arcabio.com has Semrush global rank of 1,347,189. arcabio.com has an estimated worth of US$ 7,856,584, based on its estimated Ads revenue. arcabio.com receives approximately 906,529 unique visitors each day. Its web server is located in United States, with IP address 192.252.148.190. According to SiteAdvisor, arcabio.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$7,856,584
Daily Ads Revenue	US$7,253
Monthly Ads Revenue	US$217,567
Yearly Ads Revenue	US$2,610,804
Daily Unique Visitors	60,436
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
arcabio.com.	A	7199	IP: 192.252.148.190
arcabio.com.	NS	25920	NS Record: ns1.server287.com.
arcabio.com.	NS	25920	NS Record: ns2.server287.com.
arcabio.com.	MX	3600	MX Record: 0 arcabio-com.mail.protection.outlook.com.
arcabio.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all

HtmlToTextCheckTime:2023-05-08 04:03:23

About ARCA Our Science Clinical Trials Collaborations Investors Contact Us About ARCA Our Science Clinical Trials Collaborations Investors Contact Us rNAPc2 (AB201) clinical trial enrolled patients in US, Argentina & Brazil Phase 2b Topline data reported March 2022 A Late Stage Biopharma Company Tailored Healthcare Pharmacogenetic Precision Medicine for Cardiovascular Disease 30-60% Individual patients respond differently to their disease and treatment. Only 1/3 to 2/3 of common drug therapy is successful. Atrial Fibrillation An Epidemic Cardiovascular Disease 6.2 M Estimated number of individuals diagnosed with AF in U.S. in 2016. Unmet Medical Need Safe and effective drug therapies for atrial fibrilation in patients with heart failure Zero There are currently no FDA approved drug therapies indicated for treating patients with atrial fibrillation and heart failure with left ventricular ejection fraction (LVEF) >= 40%. Gencaro™ Potentially the first genetically-targeted AF

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 29 Oct 2021 07:43:53 GMT
Server: Apache
Vary: Accept-Encoding,Cookie
X-Redirect-By: WordPress
Upgrade: h2
Connection: Upgrade
Location: https://arcabio.com/
Content-Type: text/html; charset=UTF-8

HTTP/2 200 
vary: Accept-Encoding,Cookie
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
content-type: text/html; charset=UTF-8
date: Fri, 29 Oct 2021 07:43:53 GMT
server: Apache

arcabio.com Whois Information

Domain Name: ARCABIO.COM
Registry Domain ID: 1955831555_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2021-08-28T11:23:04Z
Creation Date: 2015-08-27T22:16:57Z
Registry Expiry Date: 2022-08-27T22:16:57Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Name Server: NS1.SERVER287.COM
Name Server: NS2.SERVER287.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-16T21:51:41Z <<<

arcabio.com valuation and analysis